| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067985 Anticancer agents |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067955 Pyridazinone compound and pharmaceutical use thereof |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067938 Quaternary amines and related inhibitors of factor xa |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/08/2004 | DE10244811A1 Verfahren zur Herstellung von 3-Heteroaryl-3-hydroxy-propansäurederivaten A process for the preparation of 3-heteroaryl-3-hydroxy-propanoic acid derivatives |
| 04/08/2004 | DE10219987A1 Optisch aktive β-Aminoketone, optisch aktive 1,3-Aminoalkohole und Verfahren zu deren Herstellung Optically active β-amino ketones, optically active 1,3-aminoalcohols and processes for their preparation |
| 04/08/2004 | CA2500231A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/07/2004 | EP1405917A2 Process for the production of 3-Heteroaryl-3-hydroxy-propionic acid derivatives by enantioselective microbial reduction |
| 04/07/2004 | EP1405870A1 Monomers having rotaxane structure and polymers and processes for production of both |
| 04/07/2004 | EP1405847A1 Process to prepare substituted pyridine-N-oxide compounds |
| 04/07/2004 | EP1405636A1 Function regulator for retinoid relative receptor |
| 04/07/2004 | EP1404696A1 Activators for oligonucleotide synthesis |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404666A1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 04/07/2004 | EP1404664A1 Aminediols for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404655A1 Method for large-scale manufacture of dye for dye-sensitised solar cells |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404648A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action |
| 04/07/2004 | EP1404643A2 Cleavable surfactants and methods of use thereof |
| 04/07/2004 | EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1173411B1 Polyaldimines of oligomeric aminobenzoic acid derivatives, and their use for preparation of moisture-curable, storage-stable, one-part polyreas |
| 04/07/2004 | EP1100766B1 Crosslinkable liquid crystalline compounds |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0910370B1 Compositions comprising a nitrone compound for use in treating uveitis |
| 04/07/2004 | CN1487916A Process for the preparation of arylethanoldiamines useful as agonists the beta-3-adrenoceptor |
| 04/07/2004 | CN1487820A Primary intermediate for oxidative coloration of hair |
| 04/07/2004 | CN1487819A Primary intermediate for oxidative coloration of hair |
| 04/07/2004 | CN1487818A Primary intermediates for oxidative coloration of hair |
| 04/07/2004 | CN1487815A Novel couplers for use in oxidative hair dyeing |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/07/2004 | CN1144784C Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical composition containing them |
| 04/07/2004 | CN1144585C Animal fast biochemical accelerating composition containing cysteamine and its salt and use |
| 04/06/2004 | US6716981 Process for the preparation of N-(amino-4, 6-dihalo-pyrimidine) formamides |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716876 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 04/06/2004 | US6716860 Azo amino acids derivatives |
| 04/06/2004 | US6716859 Anticancer agents |
| 04/06/2004 | US6716858 Derivatives of vitamin b6 and vitamin b1, preferred being pyridoxamine and thiamine pyrophosphate; inhibitors of post-amadori advanced glycation end products, late maillard products; oxidative stress |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716844 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 04/06/2004 | US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 04/06/2004 | US6716596 Agents for replacement of NAD+/NADH system in enzymatic reactions |
| 04/06/2004 | CA2284646C Synthesis of intermediates useful in preparing tricyclic compounds |
| 04/06/2004 | CA2223927C Detection of transmembrane potentials by optical methods |
| 04/01/2004 | WO2004026851A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2004026816A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026806A2 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | WO2002089798A3 Method and compositions for treating migraines |
| 04/01/2004 | US20040063961 Enzyme inhibitors; antilipemic agents |
| 04/01/2004 | US20040063960 Process of preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof |
| 04/01/2004 | US20040063958 Synthesis of 2, 6-dicarboxylpyridines |
| 04/01/2004 | US20040063957 Reacting a p-nitropyridine-1-one compound with alkali metal halide in presence of phase transfer catalyst |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063763 2-methoxyimino-2(pyridinyloxymethyl)phenyl acetamides useful as fungicides |
| 04/01/2004 | US20040063761 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063758 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063640 Inhibitor of glutathione s-transferase; anticancer agents |
| 04/01/2004 | DE10244216A1 New 3,4-bis-dialkylamino-pyridine compounds, used as catalysts for the dimerization of aliphatic or cycloaliphatic di-isocyanate compounds or as acylation catalysts |
| 04/01/2004 | CA2499635A1 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |